首页 > 最新文献

Innovative Surgical Sciences最新文献

英文 中文
Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemia. 新冠肺炎疫情对德国危重肢体缺血患者截肢率的影响
IF 1.2 Q2 SURGERY Pub Date : 2024-12-18 eCollection Date: 2025-12-01 DOI: 10.1515/iss-2024-0035
Wojciech Derwich, Oliver Schöffski, Eva Herrmann, Kyriakos Oikonomou

Objectives: The COVID-19 pandemic has shown a wide range of direct and indirect influences on the health of the population. This study examines the impact of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemia (CLTI).

Methods: The epidemiological, pooled, and anonymised data of 476,168 CLTI patients from the Institute for the Hospital Remuneration System (InEK) were analysed for 2019-2023 at the federal level at weekly intervals and compared with epidemiological data for COVID-19 patients from the Robert Koch Institute (RKI) database, divided into the pandemic phases.

Results: The number of inpatient cases declined by -4.64 % (p>0.05) from 2019 to 2020 and increased significantly by +7.07 % (p=0.001) from 2020 to 2023. The incidence of all lower limb amputations increased from 2019 to 2022 (23.9 vs. 25.7 %, p=0.01) with no significant changes in 2023. Moreover, the incidence of minor amputations increased from 16.9 % in 2019 to a maximum of 18.9 % (p<0.001) in 2022, and then to 18.4 % (p=0.02) in 2023. In the short-term perspective, inpatient cases significantly decreased in phases 1 and 3, with a relevant increase in the subsequent phases. However, the incidence of all amputations, especially minor ones, is constantly increasing.

Conclusions: The COVID-19 pandemic has significantly indirectly impacted the management of CLTI patients, with a marked increase in the incidence of minor amputations, presumably due to the delayed presentation of patients with small necroses and due to limited access to healthcare.

目标:2019冠状病毒病大流行对人口健康产生了广泛的直接和间接影响。本研究探讨了COVID-19大流行对德国重症肢体威胁性缺血(CLTI)患者截肢率的影响。方法:对2019-2023年联邦一级医院薪酬制度研究所(InEK) 476168例CLTI患者的流行病学、汇总和匿名数据进行每周间隔分析,并与罗伯特·科赫研究所(RKI)数据库中COVID-19患者的流行病学数据进行比较,并按流行阶段划分。结果:2019 - 2020年住院病例数下降了-4.64 % (p>0.05), 2020 - 2023年住院病例数显著增加了+7.07 % (p=0.001)。所有下肢截肢的发生率从2019年到2022年增加(23.9比25.7 %,p=0.01), 2023年无显著变化。此外,小截肢的发生率从2019年的16.9 %增加到最高的18.9 % (p结论:COVID-19大流行显著间接影响了CLTI患者的管理,小截肢的发生率显着增加,可能是由于小坏死患者的延迟就诊和医疗保健的限制。
{"title":"Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemia.","authors":"Wojciech Derwich, Oliver Schöffski, Eva Herrmann, Kyriakos Oikonomou","doi":"10.1515/iss-2024-0035","DOIUrl":"10.1515/iss-2024-0035","url":null,"abstract":"<p><strong>Objectives: </strong>The COVID-19 pandemic has shown a wide range of direct and indirect influences on the health of the population. This study examines the impact of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemia (CLTI).</p><p><strong>Methods: </strong>The epidemiological, pooled, and anonymised data of 476,168 CLTI patients from the Institute for the Hospital Remuneration System (InEK) were analysed for 2019-2023 at the federal level at weekly intervals and compared with epidemiological data for COVID-19 patients from the Robert Koch Institute (RKI) database, divided into the pandemic phases.</p><p><strong>Results: </strong>The number of inpatient cases declined by -4.64 % (p>0.05) from 2019 to 2020 and increased significantly by +7.07 % (p=0.001) from 2020 to 2023. The incidence of all lower limb amputations increased from 2019 to 2022 (23.9 vs. 25.7 %, p=0.01) with no significant changes in 2023. Moreover, the incidence of minor amputations increased from 16.9 % in 2019 to a maximum of 18.9 % (p<0.001) in 2022, and then to 18.4 % (p=0.02) in 2023. In the short-term perspective, inpatient cases significantly decreased in phases 1 and 3, with a relevant increase in the subsequent phases. However, the incidence of all amputations, especially minor ones, is constantly increasing.</p><p><strong>Conclusions: </strong>The COVID-19 pandemic has significantly indirectly impacted the management of CLTI patients, with a marked increase in the incidence of minor amputations, presumably due to the delayed presentation of patients with small necroses and due to limited access to healthcare.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 4","pages":"211-220"},"PeriodicalIF":1.2,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12724483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145828791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstacles during training of pregnant doctors in Germany before and after COVID-19: is there a need for change? 在COVID-19之前和之后,德国怀孕医生培训中的障碍:是否需要改变?
IF 1.2 Q2 SURGERY Pub Date : 2024-12-13 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0021
Caroline Fortmann, Susanne Johna, Christiane Groß, Maya Niethard, Barbara Puhahn-Schmeiser

Objectives: With the growing proportion of female practitioners in the medical field, management of pregnant medical doctors is an increasingly important concern. The 2018 amendments to the German Maternity Protection Act stipulate that pregnant doctors and students can and should be permitted to safely continue their work under strict protective measures. Despite these measures, the reality is that pregnancy still results in limits on professional advancement and attainment for many physicians. To improve this situation, we analyzed the current situation in Germany. Based on our analysis, we identified some areas in need of improvement and offered recommendations.

Methods: We performed a nationwide online survey that was sent to medical doctors and students via the physicians' union Marburger Bund members' mailing list. The survey's main focus was on which kinds of clinical duties the pregnant doctors were assigned to, subdivided into four different time periods (under the previous and amended Maternity Protection Act, during COVID-19 pandemic and after), from 2016 to 2022.

Results: Our survey included 4,748 female medical doctors and students, with a balanced distribution across the four different time periods. The most striking restriction reported by our participants was a ban on performing surgeries and invasive procedures, an experience reported by 57-65 % of pregnant doctors and medical students before the COVID-19 pandemic and nearly 80 % since the pandemic. In addition, since the COVID-19 pandemic, a complete employment ban has been enforced upon nearly 50 % of the pregnant doctors. More than 50 % of pregnant doctors considered their careers to have been obstructed or curtailed by their pregnancies prior to the pandemic, with that number growing to two-thirds since the pandemic.

Conclusions: Pregnancy negatively impacts doctors' training and careers. Many women are not allowed to perform surgeries and invasive procedures, even while some of these practitioners report that they wish to and are capable of continuing their work. Change is needed to support enthusiastic young female doctors and students and enable them to maintain their skills and professional advancement during pregnancy.

目的:随着女性从业者在医疗领域所占比例的不断增加,怀孕医生的管理越来越受到关注。2018年《德国生育保护法》修正案规定,怀孕的医生和学生可以也应该被允许在严格的保护措施下安全地继续工作。尽管采取了这些措施,但现实情况是,怀孕仍然限制了许多医生的职业发展和成就。为了改善这种情况,我们分析了德国的现状。根据我们的分析,我们确定了一些需要改进的地方,并提出了建议。方法:我们进行了一项全国性的在线调查,该调查通过医生联盟Marburger Bund成员的邮件列表发送给医生和学生。该调查的主要重点是孕妇医生被分配了哪些临床职责,并将其细分为2016年至2022年四个不同的时间段(根据之前和修订的《产妇保护法》,在COVID-19大流行期间和之后)。结果:我们调查了4,748名女医生和女学生,在四个不同的时期分布均衡。我们的参与者报告的最引人注目的限制是禁止进行手术和侵入性手术,在COVID-19大流行之前,57% - 65% %的怀孕医生和医学生报告了这一经历,在大流行之后,这一比例接近80% %。此外,自新冠疫情以来,近50% %的怀孕医生被全面禁止就业。50%以上 %的怀孕医生认为,在大流行之前,她们的职业生涯因怀孕而受到阻碍或限制,自大流行以来,这一数字增加到三分之二。结论:妊娠对医生培训和职业生涯有不利影响。许多妇女不被允许进行手术和侵入性手术,即使其中一些医生报告说她们希望并有能力继续她们的工作。需要做出改变,支持热情的年轻女医生和女学生,使她们能够在怀孕期间保持自己的技能和专业进步。
{"title":"Obstacles during training of pregnant doctors in Germany before and after COVID-19: is there a need for change?","authors":"Caroline Fortmann, Susanne Johna, Christiane Groß, Maya Niethard, Barbara Puhahn-Schmeiser","doi":"10.1515/iss-2024-0021","DOIUrl":"10.1515/iss-2024-0021","url":null,"abstract":"<p><strong>Objectives: </strong>With the growing proportion of female practitioners in the medical field, management of pregnant medical doctors is an increasingly important concern. The 2018 amendments to the German Maternity Protection Act stipulate that pregnant doctors and students can and should be permitted to safely continue their work under strict protective measures. Despite these measures, the reality is that pregnancy still results in limits on professional advancement and attainment for many physicians. To improve this situation, we analyzed the current situation in Germany. Based on our analysis, we identified some areas in need of improvement and offered recommendations.</p><p><strong>Methods: </strong>We performed a nationwide online survey that was sent to medical doctors and students via the physicians' union Marburger Bund members' mailing list. The survey's main focus was on which kinds of clinical duties the pregnant doctors were assigned to, subdivided into four different time periods (under the previous and amended Maternity Protection Act, during COVID-19 pandemic and after), from 2016 to 2022.</p><p><strong>Results: </strong>Our survey included 4,748 female medical doctors and students, with a balanced distribution across the four different time periods. The most striking restriction reported by our participants was a ban on performing surgeries and invasive procedures, an experience reported by 57-65 % of pregnant doctors and medical students before the COVID-19 pandemic and nearly 80 % since the pandemic. In addition, since the COVID-19 pandemic, a complete employment ban has been enforced upon nearly 50 % of the pregnant doctors. More than 50 % of pregnant doctors considered their careers to have been obstructed or curtailed by their pregnancies prior to the pandemic, with that number growing to two-thirds since the pandemic.</p><p><strong>Conclusions: </strong>Pregnancy negatively impacts doctors' training and careers. Many women are not allowed to perform surgeries and invasive procedures, even while some of these practitioners report that they wish to and are capable of continuing their work. Change is needed to support enthusiastic young female doctors and students and enable them to maintain their skills and professional advancement during pregnancy.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 3","pages":"157-165"},"PeriodicalIF":1.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145372391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is the best surgical approach for esophageal cancer? 食管癌最好的手术方式是什么?
IF 1.7 Q2 SURGERY Pub Date : 2024-12-06 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0021
Verena Tripke, Vladimir J Lozanovski, Carolina Mann, Hauke Lang, Peter P Grimminger

Esophageal cancer is an aggressive tumor entity, and oncologic esophagectomy with two-field lymphadenectomy after perioperative chemotherapy or chemoradiotherapy is the standard of care for curative treatment. Oncological esophagectomy is a complex procedure associated with a relevant surgical trauma. Complications, such as severe pulmonary infections and anastomotic leakage with mediastinitis lead to a high morbidity rate. To reduce the surgical trauma, the minimally invasive technique was introduced in esophageal surgery. Minimally invasive esophagectomy is associated with less postoperative pain and a reduced rate of pulmonary infections. Currently, there are two major different totally minimally invasive techniques, the conventional laparoscopic/thoracoscopic approach (MIE) and the robotic assisted approach (RAMIE). Both methods require teaching due to the flat learning curve associated with these complex procedures. However, both MIE and RAMIE are performed safely in specialized centers. They are associated with improved short-term outcome and similar oncological outcome compared to open esophagectomy. The robotic assisted approach has additional benefits that may be supported by the results of more randomized controlled trials in the future.

食管癌是侵袭性肿瘤,围手术期化疗或放化疗后行肿瘤性食管切除术加双野淋巴结切除术是根治性治疗的标准护理。肿瘤食管切除术是一项复杂的手术,伴有相关的外科创伤。严重的肺部感染和吻合口漏合并纵隔炎等并发症导致高发病率。为了减少手术创伤,将微创技术引入食管手术。微创食管切除术术后疼痛减轻,肺部感染发生率降低。目前,主要有两种不同的全微创技术,传统的腹腔镜/胸腔镜入路(MIE)和机器人辅助入路(RAMIE)。这两种方法都需要教学,因为与这些复杂的过程相关的平坦的学习曲线。然而,MIE和RAMIE都是在专门的中心安全地进行的。与开放式食管切除术相比,它们具有改善的短期预后和相似的肿瘤预后。机器人辅助的方法有额外的好处,可能会得到未来更多随机对照试验结果的支持。
{"title":"What is the best surgical approach for esophageal cancer?","authors":"Verena Tripke, Vladimir J Lozanovski, Carolina Mann, Hauke Lang, Peter P Grimminger","doi":"10.1515/iss-2023-0021","DOIUrl":"10.1515/iss-2023-0021","url":null,"abstract":"<p><p>Esophageal cancer is an aggressive tumor entity, and oncologic esophagectomy with two-field lymphadenectomy after perioperative chemotherapy or chemoradiotherapy is the standard of care for curative treatment. Oncological esophagectomy is a complex procedure associated with a relevant surgical trauma. Complications, such as severe pulmonary infections and anastomotic leakage with mediastinitis lead to a high morbidity rate. To reduce the surgical trauma, the minimally invasive technique was introduced in esophageal surgery. Minimally invasive esophagectomy is associated with less postoperative pain and a reduced rate of pulmonary infections. Currently, there are two major different totally minimally invasive techniques, the conventional laparoscopic/thoracoscopic approach (MIE) and the robotic assisted approach (RAMIE). Both methods require teaching due to the flat learning curve associated with these complex procedures. However, both MIE and RAMIE are performed safely in specialized centers. They are associated with improved short-term outcome and similar oncological outcome compared to open esophagectomy. The robotic assisted approach has additional benefits that may be supported by the results of more randomized controlled trials in the future.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"31-35"},"PeriodicalIF":1.7,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Passage- and serum-dependent changes of adipose-derived stromal cells in vitro: a discrepancy of stemness factors regarding mesenchymal surface markers and expression of stemness-related genes. 脂肪源性基质细胞体外传代和血清依赖性变化:间充质表面标记和干性相关基因表达的干性因子差异
IF 1.2 Q2 SURGERY Pub Date : 2024-12-02 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0010
Renata Sonnenfeld, Peter M Vogt, Jörn W Kuhbier, Sarah Strauss

Objectives: Autologous fat transplantation is a promising source for cell therapy and tissue engineering. However, the physiological function and regulatory mechanisms of in vitro cell culture remain largely unexplored. Furthermore, no standard protocol for cell culture of human adipose-derived stem cells (hASC) has been described. Previous studies have reported the impact of media supplementation on the loss of stemness capacity.

Methods: In this study, we compared the expression of stemness-defining surface markers according to the minimal criteria definition (CD 11b⁻, CD 31⁻, CD 34⁻, CD 45⁻, CD 73⁺, CD 90⁺, and CD 105⁻) by flow cytometry analysis with the expression of stemness-related genes such as MCAM, OCT4, MYC, and cKit in hASCs cultured in either fetal calf serum (FCS) or human serum (HS) supplemented medium from passage 0 to 5.

Results: As expected, we found that hASCs in both groups retained their typical mesenchymal surface marker profile CD 73 and CD 90 (>95 %) in flow cytometry analysis, as well as the absence of CD 11b, CD 31, CD 34, and CD 45 (<5 %) until passage 5. However, in contrast to that, RT-PCR indicated a passage-dependent decline and medium-dependent changes in the transcriptome, in particular the loss of the stemness-related genes cKit and MCAM in both groups, while MYC and OCT4 showed unpredictable expression.

Conclusions: Summarized, these results indicate the need for standardized cell culture protocol, as the transcriptome seems to change during in vitro cultivation, although an ASC-typical pattern of surface markers remains. In this regard, our study aims to contribute to the establishment of a standard protocol to achieve reliability, validity, and objectivity for future cell therapy or clinical applications.

目的:自体脂肪移植是一种很有前途的细胞治疗和组织工程来源。然而,体外细胞培养的生理功能和调控机制在很大程度上仍未被探索。此外,人类脂肪源性干细胞(hASC)细胞培养的标准方案尚未被描述。先前的研究已经报道了培养基补充对茎干能力丧失的影响。方法:在本研究中,我们用流式细胞术比较了根据最小标准定义(CD 11b⁻,CD 31⁻,CD 34⁻,CD 45⁻,CD 73⁺,CD 90⁺和CD 105⁻)的表达,以及在胎牛血清(FCS)或人血清(HS)补充培养基中培养的hasc中,从0传代到5传代,MCAM、OCT4、MYC和cKit等干细胞相关基因的表达。结果:正如预期的那样,我们发现两组的hASCs在流式细胞术分析中都保留了其典型的间质表面标记物CD 73和CD 90 (bbb95 %),以及CD 11b, CD 31, CD 34和CD 45的缺失(结论:总结,这些结果表明需要标准化的细胞培养方案,因为在体外培养过程中转录组似乎发生了变化,尽管asc典型的表面标记物模式仍然存在。在这方面,我们的研究旨在为未来细胞治疗或临床应用建立一个标准方案,以实现可靠性,有效性和客观性。
{"title":"Passage- and serum-dependent changes of adipose-derived stromal cells <i>in vitro</i>: a discrepancy of stemness factors regarding mesenchymal surface markers and expression of stemness-related genes.","authors":"Renata Sonnenfeld, Peter M Vogt, Jörn W Kuhbier, Sarah Strauss","doi":"10.1515/iss-2024-0010","DOIUrl":"10.1515/iss-2024-0010","url":null,"abstract":"<p><strong>Objectives: </strong>Autologous fat transplantation is a promising source for cell therapy and tissue engineering. However, the physiological function and regulatory mechanisms of <i>in vitro</i> cell culture remain largely unexplored. Furthermore, no standard protocol for cell culture of human adipose-derived stem cells (hASC) has been described. Previous studies have reported the impact of media supplementation on the loss of stemness capacity.</p><p><strong>Methods: </strong>In this study, we compared the expression of stemness-defining surface markers according to the minimal criteria definition (CD 11b⁻, CD 31⁻, CD 34⁻, CD 45⁻, CD 73⁺, CD 90⁺, and CD 105⁻) by flow cytometry analysis with the expression of stemness-related genes such as MCAM, OCT4, MYC, and cKit in hASCs cultured in either fetal calf serum (FCS) or human serum (HS) supplemented medium from passage 0 to 5.</p><p><strong>Results: </strong>As expected, we found that hASCs in both groups retained their typical mesenchymal surface marker profile CD 73 and CD 90 (>95 %) in flow cytometry analysis, as well as the absence of CD 11b, CD 31, CD 34, and CD 45 (<5 %) until passage 5. However, in contrast to that, RT-PCR indicated a passage-dependent decline and medium-dependent changes in the transcriptome, in particular the loss of the stemness-related genes cKit and MCAM in both groups, while MYC and OCT4 showed unpredictable expression.</p><p><strong>Conclusions: </strong>Summarized, these results indicate the need for standardized cell culture protocol, as the transcriptome seems to change during <i>in vitro</i> cultivation, although an ASC-typical pattern of surface markers remains. In this regard, our study aims to contribute to the establishment of a standard protocol to achieve reliability, validity, and objectivity for future cell therapy or clinical applications.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 3","pages":"121-130"},"PeriodicalIF":1.2,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy. 食管癌的新辅助治疗:化疗、放化疗、免疫治疗及治疗的未来趋势。
IF 1.7 Q2 SURGERY Pub Date : 2024-11-25 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0005
Freschta Malekzada, Miljana Vladimiriov, Michael Leitz, Julia Michel, Fabian Nimzewski, Jens Hoeppner

In the Western hemisphere, nonmetastatic locally advanced esophageal carcinoma is mostly treated in multimodal therapy protocols according to current therapy guidelines. In squamous cell carcinoma of the esophagus, neoadjuvant chemoradiation is the favorable option. Unimodal surgical and chemoradiation treatment alternatives show inferior results on this entity. For locally advanced adenocarcinoma of the esophagus perioperative chemotherapy and neoadjuvant chemoradiation have been competing treatment approaches in the recent past. Both are evidence based (class I evidence) and superior compared to unimodal surgery. However, the latest results of head-to-head comparative therapy studies show superior overall survival results for the FLOT regimen of perioperative chemotherapy. Furthermore, immunotherapy and targeted therapy with monoclonal antibodies have become a strong focus of current clinical research. Nivolumab as well as trastuzumab are already an important part of the current standard therapies. In both entities - SCC and AC - a significant quota of patients shows a locoregional complete remission of the tumor in the specimen after modern neoadjuvant therapy and surgical resection. The addition of immunotherapy and targeted therapy to neoadjuvant therapy further increases complete remission rates in defined subgroups according to the results of current studies. Currently, three prospective randomized trials are ongoing on the subject of future possibilities for organ-preserving concepts in case of complete clinical remission ("surgery as needed," "watch and wait"). It is to be expected for the future that curative short-term and long-term treatment results in locally advanced esophageal carcinoma will significantly improve, particularly due to the additional possibilities of immunotherapy and organ-preserving therapy concepts in postneoadjuvant complete remission.

在西半球,根据目前的治疗指南,非转移性局部晚期食管癌大多采用多模式治疗方案。在食管鳞状细胞癌中,新辅助放化疗是有利的选择。单模手术和放化疗替代治疗显示较差的结果在这个实体。对于局部晚期食管癌,围手术期化疗和新辅助放化疗一直是相互竞争的治疗方法。两者都是基于证据的(I类证据),与单模手术相比优于单模手术。然而,最新的头对头比较治疗研究结果显示,FLOT方案围手术期化疗的总生存期优于其他方案。此外,免疫治疗和单克隆抗体靶向治疗已成为当前临床研究的热点。纳武单抗和曲妥珠单抗已经是目前标准治疗的重要组成部分。在SCC和AC这两种肿瘤中,在现代新辅助治疗和手术切除后,有相当一部分患者的标本显示肿瘤局部完全缓解。根据目前的研究结果,在新辅助治疗的基础上增加免疫治疗和靶向治疗进一步提高了定义亚组的完全缓解率。目前,三个前瞻性随机试验正在进行中,主题是在完全临床缓解的情况下器官保存概念的未来可能性(“根据需要进行手术”,“观察和等待”)。可以预期,局部晚期食管癌的短期和长期治疗结果将显著改善,特别是由于免疫治疗和器官保留治疗概念在新辅助后完全缓解中的额外可能性。
{"title":"Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy.","authors":"Freschta Malekzada, Miljana Vladimiriov, Michael Leitz, Julia Michel, Fabian Nimzewski, Jens Hoeppner","doi":"10.1515/iss-2023-0005","DOIUrl":"10.1515/iss-2023-0005","url":null,"abstract":"<p><p>In the Western hemisphere, nonmetastatic locally advanced esophageal carcinoma is mostly treated in multimodal therapy protocols according to current therapy guidelines. In squamous cell carcinoma of the esophagus, neoadjuvant chemoradiation is the favorable option. Unimodal surgical and chemoradiation treatment alternatives show inferior results on this entity. For locally advanced adenocarcinoma of the esophagus perioperative chemotherapy and neoadjuvant chemoradiation have been competing treatment approaches in the recent past. Both are evidence based (class I evidence) and superior compared to unimodal surgery. However, the latest results of head-to-head comparative therapy studies show superior overall survival results for the FLOT regimen of perioperative chemotherapy. Furthermore, immunotherapy and targeted therapy with monoclonal antibodies have become a strong focus of current clinical research. Nivolumab as well as trastuzumab are already an important part of the current standard therapies. In both entities - SCC and AC - a significant quota of patients shows a locoregional complete remission of the tumor in the specimen after modern neoadjuvant therapy and surgical resection. The addition of immunotherapy and targeted therapy to neoadjuvant therapy further increases complete remission rates in defined subgroups according to the results of current studies. Currently, three prospective randomized trials are ongoing on the subject of future possibilities for organ-preserving concepts in case of complete clinical remission (\"surgery as needed,\" \"watch and wait\"). It is to be expected for the future that curative short-term and long-term treatment results in locally advanced esophageal carcinoma will significantly improve, particularly due to the additional possibilities of immunotherapy and organ-preserving therapy concepts in postneoadjuvant complete remission.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"3-9"},"PeriodicalIF":1.7,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periprosthetic joint infections - a scoping review. 假体周围关节感染-范围综述。
IF 1.7 Q2 SURGERY Pub Date : 2024-11-20 eCollection Date: 2024-12-01 DOI: 10.1515/iss-2024-0016
Yasmin Youssef, Annika Hättich, Kim Lydia Klepka

Periprosthetic joint infections (PJIs) are dramatic complications after primary total joint arthroplasty. Despite increasing research in this field, the diagnosis, classification, and management of PJI remain a challenge. This is mainly due to the heterogenous clinical presentation of PJI in clinical routine and patient-related factors as secondary diagnosis and periprosthetic tissue condition. The early detection of PJI is essential for adequate treatment. However, there is no definition for PJI with 100 % sensitivity or a negative predictive value. This can potentially lead to a delayed or missed diagnosis of PJI. Furthermore, the surgical and antibiotic treatment is among the most discussed topics in PJI literature. There is no international consensus on the treatment of different PJI entities. Concludingly many aspects of PJI diagnostics and treatment remain controversially discussed and current studies are only comparable to a limited extent due to study heterogeneity and limited comparability.

假体周围关节感染(PJI)是初级全关节成形术后的严重并发症。尽管该领域的研究日益增多,但 PJI 的诊断、分类和管理仍是一项挑战。这主要是由于 PJI 在临床常规中的临床表现不尽相同,以及与患者相关的继发性诊断和假体周围组织状况等因素。早期发现 PJI 对进行适当治疗至关重要。然而,目前对 PJI 的定义还没有 100% 的灵敏度或阴性预测值。这有可能导致 PJI 诊断延迟或漏诊。此外,手术和抗生素治疗也是 PJI 文献中讨论最多的话题之一。目前,国际上尚未就不同 PJI 实体的治疗方法达成共识。总之,PJI 诊断和治疗的许多方面仍存在争议,由于研究的异质性和有限的可比性,目前的研究仅具有有限的可比性。
{"title":"Periprosthetic joint infections - a scoping review.","authors":"Yasmin Youssef, Annika Hättich, Kim Lydia Klepka","doi":"10.1515/iss-2024-0016","DOIUrl":"10.1515/iss-2024-0016","url":null,"abstract":"<p><p>Periprosthetic joint infections (PJIs) are dramatic complications after primary total joint arthroplasty. Despite increasing research in this field, the diagnosis, classification, and management of PJI remain a challenge. This is mainly due to the heterogenous clinical presentation of PJI in clinical routine and patient-related factors as secondary diagnosis and periprosthetic tissue condition. The early detection of PJI is essential for adequate treatment. However, there is no definition for PJI with 100 % sensitivity or a negative predictive value. This can potentially lead to a delayed or missed diagnosis of PJI. Furthermore, the surgical and antibiotic treatment is among the most discussed topics in PJI literature. There is no international consensus on the treatment of different PJI entities. Concludingly many aspects of PJI diagnostics and treatment remain controversially discussed and current studies are only comparable to a limited extent due to study heterogeneity and limited comparability.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"9 4","pages":"191-197"},"PeriodicalIF":1.7,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional survey of the safety attitudes questionnaire subscale stress recognition and the effect of non-technical skills training in operating theatre staff. 手术室工作人员安全态度问卷亚量表压力认知及非技术技能培训效果的横断面调查。
IF 1.2 Q2 SURGERY Pub Date : 2024-11-20 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0025
Sebastian Leuschner, Philipp Schenk, Carolin Gräbsch, Frank Siemers

Objectives: Non-technical skills (NTS) training of surgical staff is a quality improvement measure to improve patient safety. One factor that can compromise patient safety is impaired staff performance due to stressors such as tiredness. Awareness of the impact of such stressors is measured by the stress recognition (SR) domain of the Safety Attitudes Questionnaire (SAQ). The aim of this study was to assess whether NTS training improves SR scores and whether there are any groups with divergent SR scores.

Methods: A cross-sectional survey of all operating theatre staff in a German major trauma centre was undertaken using the stress recognition (SR) subscale of the SAQ. A multivariable linear regression was performed to assess which factors are associated with SR scores. Data are presented as median (interquartile range).

Results: From 226 invited staff members, 89 responses (39 %) were received. Twenty-eight respondents (31 %) had attended NTS training. The overall SR score was 4.3 (3.5-4.5). There was no effect of NTS training, age, gender, profession, or specialty on SR scores. Physicians in leadership positions had lower SR scores (3.4 (3.06-4.0)) than physicians without leadership positions (4.5 (4.3-5.0), p<0.001).

Conclusions: Attendance at NTS training courses did not improve SR scores in the clinical staff of operating theatres of a German major trauma centre. Interestingly, physicians in leadership positions had lower SR scores than other physicians. Further studies using the SAQ should discriminate between physicians in leadership positions and other physicians when reporting SR scores.

目的:对外科人员进行非技术技能培训是提高患者安全的一项质量改进措施。可能危及患者安全的一个因素是由于疲劳等压力因素导致的工作人员绩效受损。安全态度问卷(SAQ)中的压力识别(SR)域测量了对这些压力源影响的认识。本研究的目的是评估NTS训练是否能提高SR得分,以及是否存在不同组的SR得分。方法:采用SAQ的压力识别(SR)量表对德国一家主要创伤中心的所有手术室工作人员进行横断面调查。采用多变量线性回归来评估哪些因素与SR评分相关。数据以中位数(四分位数范围)表示。结果:在226名被邀请的工作人员中,收到89份回复(39% %)。28名受访者(31% %)曾参加国税厅培训。总体SR评分为4.3分(3.5-4.5分)。NTS训练、年龄、性别、职业或专业对SR得分没有影响。担任领导职务的医生的SR得分(3.4(3.06-4.0))低于没有担任领导职务的医生(4.5(4.3-5.0))。结论:参加NTS培训课程并没有提高德国某创伤中心手术室临床工作人员的SR得分。有趣的是,处于领导地位的医生的SR得分低于其他医生。使用SAQ的进一步研究应该在报告SR分数时区分领导职位的医生和其他医生。
{"title":"A cross-sectional survey of the safety attitudes questionnaire subscale stress recognition and the effect of non-technical skills training in operating theatre staff.","authors":"Sebastian Leuschner, Philipp Schenk, Carolin Gräbsch, Frank Siemers","doi":"10.1515/iss-2024-0025","DOIUrl":"10.1515/iss-2024-0025","url":null,"abstract":"<p><strong>Objectives: </strong>Non-technical skills (NTS) training of surgical staff is a quality improvement measure to improve patient safety. One factor that can compromise patient safety is impaired staff performance due to stressors such as tiredness. Awareness of the impact of such stressors is measured by the stress recognition (SR) domain of the Safety Attitudes Questionnaire (SAQ). The aim of this study was to assess whether NTS training improves SR scores and whether there are any groups with divergent SR scores.</p><p><strong>Methods: </strong>A cross-sectional survey of all operating theatre staff in a German major trauma centre was undertaken using the stress recognition (SR) subscale of the SAQ. A multivariable linear regression was performed to assess which factors are associated with SR scores. Data are presented as median (interquartile range).</p><p><strong>Results: </strong>From 226 invited staff members, 89 responses (39 %) were received. Twenty-eight respondents (31 %) had attended NTS training. The overall SR score was 4.3 (3.5-4.5). There was no effect of NTS training, age, gender, profession, or specialty on SR scores. Physicians in leadership positions had lower SR scores (3.4 (3.06-4.0)) than physicians without leadership positions (4.5 (4.3-5.0), p<0.001).</p><p><strong>Conclusions: </strong>Attendance at NTS training courses did not improve SR scores in the clinical staff of operating theatres of a German major trauma centre. Interestingly, physicians in leadership positions had lower SR scores than other physicians. Further studies using the SAQ should discriminate between physicians in leadership positions and other physicians when reporting SR scores.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 3","pages":"151-156"},"PeriodicalIF":1.2,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's new in surgery? Essentials 2024 - young patients and fast decisions. 外科手术有什么新进展?2024年要点:年轻患者和快速决策。
IF 1.7 Q2 SURGERY Pub Date : 2024-11-15 eCollection Date: 2024-12-01 DOI: 10.1515/iss-2024-0038
Juliane Kröplin
{"title":"What's new in surgery? Essentials 2024 - young patients and fast decisions.","authors":"Juliane Kröplin","doi":"10.1515/iss-2024-0038","DOIUrl":"10.1515/iss-2024-0038","url":null,"abstract":"","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"9 4","pages":"165"},"PeriodicalIF":1.7,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638820/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active surveillance in patients with a complete clinical response after neoadjuvant chemoradiotherapy for esophageal- and gastroesophageal junction cancer. 食管癌和胃食管癌新辅助放化疗后临床反应完全的患者的主动监测。
IF 1.7 Q2 SURGERY Pub Date : 2024-11-07 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0010
Tamara J Huizer, Sjoerd M Lagarde, Joost J M E Nuyttens, Lindsey Oudijk, Manon C W Spaander, Roelf Valkema, Bianca Mostert, Bas P L Wijnhoven

Neoadjuvant chemoradiotherapy in patients with esophageal- and gastroesophageal junction cancer induces tumor regression. In approximately one fourth of patients, this leads to a pathological complete response in the resection specimen. Hence, active surveillance may be an alternative strategy in patients without residual disease after neoadjuvant chemoradiotherapy. Previous studies have shown that the combination of esophagogastroduodenoscopy with bite-on-bite biopsies, endoscopic ultrasound with fine needle aspiration of suspected lymph nodes, and a PET-CT-scan can be considered adequate for the detection of residual disease. So far, it has been unclear whether active surveillance with surgery as needed is a safe treatment option and leads to non-inferior overall survival compared to standard esophagectomy after neoadjuvant chemoradiotherapy. This review will discuss the current status of active surveillance for esophageal and junctional cancer.

食管癌和胃食管癌患者的新辅助放化疗可诱导肿瘤消退。在大约四分之一的患者中,这导致切除标本的病理完全缓解。因此,主动监测可能是新辅助放化疗后无残留疾病患者的替代策略。既往研究表明,食管胃十二指肠镜联合咬对咬活检,内镜超声联合细针穿刺可疑淋巴结,pet - ct扫描可被认为足以检测残留病变。到目前为止,还不清楚主动监测和手术是否是一种安全的治疗选择,并且与新辅助放化疗后的标准食管切除术相比,是否可以获得不低于标准的总生存率。本文将讨论食管癌和结直肠癌主动监测的现状。
{"title":"Active surveillance in patients with a complete clinical response after neoadjuvant chemoradiotherapy for esophageal- and gastroesophageal junction cancer.","authors":"Tamara J Huizer, Sjoerd M Lagarde, Joost J M E Nuyttens, Lindsey Oudijk, Manon C W Spaander, Roelf Valkema, Bianca Mostert, Bas P L Wijnhoven","doi":"10.1515/iss-2023-0010","DOIUrl":"10.1515/iss-2023-0010","url":null,"abstract":"<p><p>Neoadjuvant chemoradiotherapy in patients with esophageal- and gastroesophageal junction cancer induces tumor regression. In approximately one fourth of patients, this leads to a pathological complete response in the resection specimen. Hence, active surveillance may be an alternative strategy in patients without residual disease after neoadjuvant chemoradiotherapy. Previous studies have shown that the combination of esophagogastroduodenoscopy with bite-on-bite biopsies, endoscopic ultrasound with fine needle aspiration of suspected lymph nodes, and a PET-CT-scan can be considered adequate for the detection of residual disease. So far, it has been unclear whether active surveillance with surgery as needed is a safe treatment option and leads to non-inferior overall survival compared to standard esophagectomy after neoadjuvant chemoradiotherapy. This review will discuss the current status of active surveillance for esophageal and junctional cancer.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"11-19"},"PeriodicalIF":1.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of different parameters on the outcome of vv-ECMO therapy in burn patients - a retrospective cohort study from a burn and high output ECMO center. 不同参数对烧伤患者vv-ECMO治疗结果的影响——一项来自烧伤和高输出ECMO中心的回顾性队列研究
IF 1.2 Q2 SURGERY Pub Date : 2024-09-16 eCollection Date: 2025-06-01 DOI: 10.1515/iss-2024-0024
Alperen S Bingoel, Frederik Schlottmann, Clarissa Plinke, Khaled Dastagir, Doha Obed, Anieto Enechukwu, Thorben Dieck, Lukas Wellkamp, Jasmin Sarah Hanke, Christian Kühn, Arjang Ruhparwar, Nicco Krezdorn, Peter M Vogt

Objectives: The treatment of acute respiratory distress syndrome (ARDS) in burn patients remains a major challenge. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) is a standard treatment for severe ARDS today. But reports on survival outcome in burn patients remain variable in the literature. The aim of this study is to identify factors that may influence survival and therapy outcomes in this distinct patient population.

Methods: A single-center retrospective study was conducted in the burn intensive care unit (BICU). Inclusion criteria were the use of vv-ECMO for ARDS after burn injuries. The data analyzed included general medical data and various parameters from the BICU.

Results: Between January 2012 and December 2022, 21 consecutive adult patients were identified who underwent vv-ECMO treatment. Five patients (24 %) survived the therapy and could be discharged, and 16 patients (76 %) succumbed to their disease. A higher TBSA affected, lower pH in arterial blood gas analysis after 24 and 36 h, multiorgan dysfunction syndrome (MODS), renal insufficiency, and renal replacement therapy were significantly associated with a lethal outcome.

Conclusions: The data from the present study showed an overall mortality rate of 76 %, which is unsatisfactory compared to the literature. This could be explained by complicating factors such as MODS, renal failure, and renal replacement therapy. However, the indication for vv-ECMO must be adapted to the individual situation of the respective patient. Due to the additional higher risk for complications, the utilization of ECMO therapy should be reserved for specialized burn centers with an interdisciplinary setting.

目的:烧伤患者急性呼吸窘迫综合征(ARDS)的治疗仍然是一个重大挑战。静脉-静脉体外膜氧合(vv-ECMO)是当今严重ARDS的标准治疗方法。但文献中关于烧伤患者生存结果的报道仍存在差异。本研究的目的是确定可能影响这一独特患者群体的生存和治疗结果的因素。方法:在烧伤重症监护病房(BICU)进行单中心回顾性研究。纳入标准是在烧伤后使用vv-ECMO治疗ARDS。分析的数据包括一般医疗数据和BICU的各种参数。结果:2012年1月至2022年12月,21例连续接受vv-ECMO治疗的成年患者。治疗后5例(24 %)存活出院,16例(76 %)死亡。24和36 h后较高的TBSA、较低的动脉血气分析pH值、多器官功能障碍综合征(MODS)、肾功能不全和肾脏替代治疗与致死结果显著相关。结论:本研究的数据显示,总死亡率为76% %,与文献相比,这是令人不满意的。这可以解释为复杂的因素,如MODS,肾功能衰竭和肾脏替代治疗。然而,vv-ECMO的适应症必须适应各自患者的个体情况。由于并发症的风险较高,ECMO治疗的使用应保留在具有跨学科设置的专业烧伤中心。
{"title":"Impact of different parameters on the outcome of vv-ECMO therapy in burn patients - a retrospective cohort study from a burn and high output ECMO center.","authors":"Alperen S Bingoel, Frederik Schlottmann, Clarissa Plinke, Khaled Dastagir, Doha Obed, Anieto Enechukwu, Thorben Dieck, Lukas Wellkamp, Jasmin Sarah Hanke, Christian Kühn, Arjang Ruhparwar, Nicco Krezdorn, Peter M Vogt","doi":"10.1515/iss-2024-0024","DOIUrl":"10.1515/iss-2024-0024","url":null,"abstract":"<p><strong>Objectives: </strong>The treatment of acute respiratory distress syndrome (ARDS) in burn patients remains a major challenge. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) is a standard treatment for severe ARDS today. But reports on survival outcome in burn patients remain variable in the literature. The aim of this study is to identify factors that may influence survival and therapy outcomes in this distinct patient population.</p><p><strong>Methods: </strong>A single-center retrospective study was conducted in the burn intensive care unit (BICU). Inclusion criteria were the use of vv-ECMO for ARDS after burn injuries. The data analyzed included general medical data and various parameters from the BICU.</p><p><strong>Results: </strong>Between January 2012 and December 2022, 21 consecutive adult patients were identified who underwent vv-ECMO treatment. Five patients (24 %) survived the therapy and could be discharged, and 16 patients (76 %) succumbed to their disease. A higher TBSA affected, lower pH in arterial blood gas analysis after 24 and 36 h, multiorgan dysfunction syndrome (MODS), renal insufficiency, and renal replacement therapy were significantly associated with a lethal outcome.</p><p><strong>Conclusions: </strong>The data from the present study showed an overall mortality rate of 76 %, which is unsatisfactory compared to the literature. This could be explained by complicating factors such as MODS, renal failure, and renal replacement therapy. However, the indication for vv-ECMO must be adapted to the individual situation of the respective patient. Due to the additional higher risk for complications, the utilization of ECMO therapy should be reserved for specialized burn centers with an interdisciplinary setting.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 2","pages":"73-80"},"PeriodicalIF":1.2,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12327721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144800493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Innovative Surgical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1